Indication
Acute coronary syndrome
Acute coronary syndrome is an umbrella term for a continuum of life-threatening cardiovascular conditions caused by an abrupt reduction in blood flow through the coronary arteries, leading to acute myocardial ischemia or infarction. Read more about Acute coronary syndrome
224 drugs 152 manufacturers
Drugs that treat it
Common Acute coronary syndrome therapies.
ASPIRIN
METOPROLOL TARTRATE
METOPROLOL TARTRATE
TICAGRELOR
ASPIRIN
TICAGRELOR
TICAGRELOR
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAcute coronary syndrome is an umbrella term for a continuum of life-threatening cardiovascular conditions caused by an abrupt reduction in blood flow through the coronary arteries, leading to acute myocardial ischemia or infarction.
Primarily affecting adults with underlying coronary artery disease, it encompasses unstable angina, non–ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction.
Pathophysiologically, the syndrome is most commonly precipitated by atherosclerotic plaque disruption—such as rupture or superficial erosion—followed by platelet activation and thrombosis, leading to partial or total vascular occlusion.
Clinically, it presents with ischemic symptoms, classic electrocardiographic alterations, and varying degrees of myocardial necrosis evidenced by elevated cardiac biomarkers such as troponin.
- nih.gov
Acute coronary syndrome is an umbrella term for a continuum of life-threatening cardiovascular conditions caused by an abrupt reduction in blood flow through the coronary arteries, leading to acute myocardial ischemia or infarction Primarily affecting adults with underlying coronary artery disease, it encompasses unstable angina, non–ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction Pathophysiologically, the syndrome is most commonly precipitated by ather...
- nih.gov
Acute coronary syndrome is an umbrella term for a continuum of life-threatening cardiovascular conditions caused by an abrupt reduction in blood flow through the coronary arteries, leading to acute myocardial ischemia or infarction Pathophysiologically, the syndrome is most commonly precipitated by atherosclerotic plaque disruption—such as rupture or superficial erosion—followed by platelet activation and thrombosis, leading to partial or total vascular occlusion Clinically, it presents with isc...
- nih.gov
Primarily affecting adults with underlying coronary artery disease, it encompasses unstable angina, non–ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction
- nih.gov
Pathophysiologically, the syndrome is most commonly precipitated by atherosclerotic plaque disruption—such as rupture or superficial erosion—followed by platelet activation and thrombosis, leading to partial or total vascular occlusion
- nih.gov
Clinically, it presents with ischemic symptoms, classic electrocardiographic alterations, and varying degrees of myocardial necrosis evidenced by elevated cardiac biomarkers such as troponin
- nih.gov
Clinically, it presents with ischemic symptoms, classic electrocardiographic alterations, and varying degrees of myocardial necrosis evidenced by elevated cardiac biomarkers such as troponin
Personalize your experience
Follow Acute coronary syndrome and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.